Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy
暂无分享,去创建一个
H. Sasano | N. Masuda | H. Yamashita | M. Toi | S. Ohno | T. Ueno | E. Fakhrejahani | K. Aogi | T. Morimoto | T. Nakayama | M. Kashiwaba | N. Yoshida | K. Kuroi | H. Bando | F. Takahashi | N. Sato | S. Kamigaki | Y. Ito | Shinichirou Nakamura | N. Sato | H. Iwata | L. Chow | K. Hisamatsu | S. Nakamura | Y. Yamamoto | K. Hisamatsu | Hironobu Sasano | Noriyuki Yoshida | Takayuki Ueno | Shinji Ohno | Lwc Chow | Fumiaki Takahashi | Takashi Morimoto | Hiroko Yamashita | Yoshinori Ito | Yutaka Yamamoto | M. Toi